Press releases
- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Key statistics
As of last trade, Kezar Life Sciences Inc (2KZ:FRA) traded at 0.496, 18.66% above the 52 week low of 0.418 set on Jun 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.496 |
---|---|
High | 0.496 |
Low | 0.496 |
Bid | 0.496 |
Offer | 0.565 |
Previous close | 0.496 |
Average volume | 0.00 |
---|---|
Shares outstanding | 72.80m |
Free float | 62.00m |
P/E (TTM) | -- |
Market cap | 42.16m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 07:03 BST.
More ▼